Activities of Antonyia PARVANOVA related to 2008/0142(COD)
Plenary speeches (1)
Patients’ rights in cross-border healthcare (debate)
Amendments (12)
Amendment 109 #
Council position
Recital 19 a (new)
Recital 19 a (new)
(19a) It is also important to put in place measures to ensure that women have equitable access to public health schemes and care that are specific to them, particularly gynaecological and reproductive healthcare.
Amendment 111 #
Council position
Recital 21
Recital 21
(21) Ensuring clear common obligations in respect of the provision of mechanisms for responding to harm arising from healthcare, including the provision of aftercare, is essential to prevent lack of confidence in those mechanisms being an obstacle to taking up cross-border healthcare. Systems for addressing harm in the Member State of treatment should be without prejudice to the possibility for Member States to extend the coverage of their domestic systems to patients from their country seeking healthcare abroad, where this is more appropriate for the patient.
Amendment 125 #
Council position
Recital 44
Recital 44
(44) The Member States should decide on the form and number of their national contact points. Such national contact points may also be incorporated in, or build on, activities of existing information centres provided that it is clearly indicated that they are also national contact points for cross-border healthcare. The national contact points should have appropriate facilities to provide information on the main aspects of cross-border healthcare. The Commission should work together with the Member States in order to facilitate cooperation regarding national contact points for cross-border healthcare, including making relevant information available at Union level. The existence of national contact points should not preclude Member States from establishing other linked contact points at regional or local level, reflecting the specific organisation of their healthcare system. The national contact points should be able to provide patients with relevant information on cross-border healthcare, and to advise and assist them. This should not include legal advice.
Amendment 129 #
Council position
Recital 49 a (new)
Recital 49 a (new)
(49a) The interoperability of e-health solutions should be achieved whilst respecting national regulations on the provision of health services adopted in order to protect the patient, including legislation on internet pharmacies, in particular national bans on mail order of prescription-only medicinal products in accordance with the case law of the Court of Justice and Directive 97/7/EC of the European Parliament and of the Council of 20 May 1997 on the protection of consumers in respect of distance contracts. 1 OJ L 144, 4.6.1997, p. 19.
Amendment 134 #
Council position
Article 1 – paragraph 1
Article 1 – paragraph 1
1. This Directive provides rules for facilitating the access to safe and high- quality cross-border healthcare and promotes cooperation on healthcare between Member States, in full respect of national competencies in organising and delivering healthcare. In the application of this Directive, Member States shall take into account the principles of good quality care and equity.
Amendment 159 #
Council position
Article 6 – paragraph 2
Article 6 – paragraph 2
2. National contact points shall facilitate the exchange of information referred to in paragraph 3 and cooperate closely with each other and with the Commission. National contact points shall provide patients on request with contact details of national contact points in other Member States.
Amendment 162 #
Council position
Article 6 – paragraph 3
Article 6 – paragraph 3
3. National contact points in the Member State of treatment shall provide patients with information concerning healthcare providers, including on request information on a specific provider's right to provide services or any restrictions on its practice, information referred to in Article 4(2)(a), as well as information on patients' rights, complaints procedures and mechanisms for seeking remedies, according to the legislation of that Member State. The national contact point shall inform patients about their rights and help them to seek appropriate redress in the event of harm arising from healthcare received in another Member State.
Amendment 186 #
Council position
Article 8 – paragraph 5 – point c
Article 8 – paragraph 5 – point c
(c) if the patient will, according to a clinical evaluation, be exposed with reasonable certainty to a patient-safety risk that cannot be regarded as acceptable, taking into account the potential benefit for the patient of the sought cross-border healthcare. In the event of a patient suffering from a rare disease, this clinical evaluation shall be carried out by recognised experts in that field;
Amendment 209 #
Council position
Article 12 – paragraph 2 – point e
Article 12 – paragraph 2 – point e
(e) facilitate mobility of expertise, virtually or physically, and to develop, share and spread information, knowledge and best practice and, in particular, to foster developments of the diagnosis of rare diseases, within and outside the networks;
Amendment 219 #
Council position
Article 14 – paragraph 1
Article 14 – paragraph 1
1. The Union shall support and facilitate cooperation and the exchange of scientific information among Member States within a voluntaryFor this purpose, the Commission shall, in consultation with the European Parliament, facilitate the establishment of a network connecting national authorities or bodies responsible for health technology assessment designated by the Member States. The members of the network shall participate in, and contribute to, the network's activities in accordance with the legislation of the Member State where they are established. That network shall be based on the principles of good governance including transparency, objectivity, independence of expertise, fairness of procedures, and broad stakeholder participation from all relevant groups, including - but not limited to - health professionals, patients' representatives, social partners, scientists and industry, whilst respecting Member States' competence in the area of health technology assessment. Names of experts and individuals participating to the network's activities should be publicly available, together with their declaration of interest.
Amendment 221 #
Council position
Article 14 – paragraph 2 – point b
Article 14 – paragraph 2 – point b
(b) support Member States in the provision of objective, reliable, timely, transparent, comparable and transferable scientific information on the relative efficacy in real conditions of use or application, as well as on the short- and long-term effectiveness when applicable, of health technologies, and to enable an effective exchange of this information between the national authorities or bodies.
Amendment 227 #
Council position
Article 20 – paragraph 1 – subparagraph 1
Article 20 – paragraph 1 – subparagraph 1
1. Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by….** They shall forthwith inform the Commission thereof. ** OJ: 31 years from the date of entry into force of this Directive.